Relevium Announces Delay in Filing Annual Financial Statements
November 01 2021 - 05:14PM
Relevium Technologies Inc. (TSX-V : RLV, OTC : RLLVF, and
Frankfurt : 6BX) (the “
Company” or
“
Relevium”) announces that its annual financial
statements for the year ended June 30, 2021, including the related
management discussion and analysis, and CEO and CFO certifications
(collectively, the “
Annual Financial Filings”)
have not been filed by the required filing deadline of October 28,
2021 (the “
Filing Deadline”).
The Annual Financial Filings were not filed
before the Filing Deadline due to audit resource scheduling and
availability required to complete the financial statements and
disclosures. The Company is working on the steps required to
complete the Annual Financial Filings and expects to be able to
file the Annual Financial Filings by January 31, 2022. The Company
will provide updates as further information relating to the Annual
Financial Filings becomes available.
The Company has applied to the applicable
securities regulatory authorities and received a management cease
trade order (“MCTO”) imposed against the Chief
Executive Officer, the Chief Financial Officer and the directors of
the Company precluding them from trading securities of the Company.
The MCTO will be in effect until the Annual Financial Filings are
filed and requires that the Annual Financial Filings be filed on or
before January 31, 2022.
Until the Annual Financial Filings are filed,
the Company intends to issue bi-weekly default status reports in
accordance with National Policy 12-203 - Management Cease Trade
Orders. The Company intends to satisfy the provisions of the
Alternative Information Guidelines during the period it remains in
default of the filing requirements. The Company confirms that there
is no other material information relating to its affairs that has
not been generally disclosed.
About Relevium Technologies
Relevium Technologies Inc., is a publicly traded
Company, focused on international procurement, logistics, and
delivery of Personal Protective Equipment (“PPE”) into the North
American marketplace. Utilizing trusted vendors and suppliers, and
integrating a comprehensive, state-of-the-art supply chain,
Artificial Intelligence (“AI”), and Blockchain technology, enables
a highly secure and compliant platform for delivery of PPE
equipment to Governments, Hospitals, Foundations, and various
Institutions. Biocannabix Health Corporation, a wholly owned
subsidiary of Relevium Technologies Inc., is focused on Pediatric
and Geriatric applications of Cannabinoid formulations,
nutraceuticals, and medical food formulations. The principal
business of the Company is pursuing ongoing Research and
Development for the identification, evaluation, acquisition and
operation of brands and businesses in the health and wellness
markets and cannabinoid therapeutics.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in policies
of the TSX Venture Exchange) accepts responsibility for the
adequacy or accuracy of this release.
Cautionary Note Regarding
Forward-Looking StatementsThis release includes certain
statements and information that may constitute forward-looking
information within the meaning of applicable Canadian securities
laws. All statements in this news release, other than statements of
historical facts, including statements regarding future estimates,
plans, objectives, assumptions, or expectations of future
performance, including the timing and completion of the proposed
acquisition and the terms thereof, are forward-looking statements
and contain forward-looking information. Generally, forward-
looking statements and information can be identified by the use of
forward-looking terminology such as "intends" or "anticipates", or
variations of such words and phrases or statements that certain
actions, events, or results "may", "could", "should", "would" or
"occur".
Forward-looking statements are based on certain
material assumptions and analysis made by the Company and the
opinions and estimates of management as of the date of this press
release, including the assumptions that the Company will be able to
satisfy the conditions to complete the proposed acquisition.
These forward-looking statements are subject to
known and unknown risks, uncertainties and other factors that may
cause the actual results, level of activity, performance, or
achievements of the Company to be materially different from those
expressed or implied by such forward-looking statements or
forward-looking information. Important factors that may cause
actual results to vary, include, without limitation, the risk that
the Company is unable to satisfy the conditions of closing the
proposed acquisition including receipt of all necessary regulatory
approvals.
Although management of the Company has attempted
to identify important factors that could cause actual results to
differ materially from those contained in forward-looking
statements or forward-looking information, there may be other
factors that cause results not to be as anticipated, estimated or
intended. There can be no assurance that such statements will prove
to be accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward- looking
statements and forward-looking information. Readers are cautioned
that reliance on such information may not be appropriate for other
purposes. The Company does not undertake to update any
forward-looking statement, forward-looking information or financial
outlook that are incorporated by reference herein, except in
accordance with applicable securities laws. We seek safe
harbor.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES
INC.
Aurelio UsechePresident and CEO
For more information about this press release:
Tel: +1.888.528.8687
RELEVIUM TECHNOLOGIES INCEmail:
investors@releviumcorp.com Website: www.releviumtechnologies.com
Like us on FacebookFollow us on Twitter Follow us on LinkedIn
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Feb 2024 to Mar 2024
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Mar 2023 to Mar 2024